 |
||||
|
||||
|
||||
|
||||
.gif?ad=17923&adview=true)
Previous Article | Next Article
The Journal of Neuroscience, December 15, 2001, 21(24):9917-9929
Control of Dorsal Raphe Serotonergic Neurons by the Medial Prefrontal Cortex: Involvement of Serotonin-1A, GABAA, and Glutamate Receptors
Pau Celada, M. Victoria Puig, Josep M. Casanovas, Gemma Guillazo, and Francesc Artigas Department of Neurochemistry, Institut d' Investigacions Biomèdiques de Barcelona, Consejo Superior de Investigaciones Científicas (Institut d'Investigacions Biomèdiques August Pi i Sunyer), 08036 Barcelona, Spain
Anatomical evidence indicates that medial prefrontal cortex (mPFC) neurons project to the dorsal raphe nucleus (DR). In this study, we functionally characterized this descending pathway in rat brain. Projection neurons in the mPFC were identified by antidromic stimulation from the DR. Electrical stimulation of the mPFC mainly inhibited the activity of DR 5-HT neurons (55 of 66). Peristimulus time histograms showed a silence of 150 ± 9 msec poststimulus (latency, 36 ± 1 msec). The administration of WAY-100635 and picrotoxinin partly reversed this inhibition, indicating the involvement of 5-HT1A and GABAA receptors. In rats depleted of 5-HT with p-chlorophenylalanine, the electrical stimulation of mPFC mainly activated 5-HT neurons (31 of 40). The excitations (latency, 17 ± 1 msec) were antagonized by MK-801 and NBQX. Likewise, MK-801 prevented the rise in DR 5-HT release induced by electrical stimulation of mPFC. The application of 8-OH-DPAT in mPFC significantly inhibited the firing rate of DR 5-HT neurons and, in dual-probe microdialysis experiments, reduced the 5-HT output in mPFC and DR. Furthermore, the application of WAY-100635 in mPFC significantly antagonized the reduction of 5-HT release produced by systemic 8-OH-DPAT administration in both areas. These results indicate the existence of a complex regulation of DR 5-HT neurons by mPFC afferents. The stimulus-induced excitation of some 5-HT neurons by descending excitatory fibers releases 5-HT, which inhibits the same or other DR neurons by acting on 5-HT1A autoreceptors. Afferents from the mPFC also inhibit 5-HT neurons through the activation of GABAergic interneurons. Ascending serotonergic pathways may control the activity of this descending pathway by acting on postsynaptic 5-HT1A receptors.
Key words: 5-hydroxytryptamine; 5-HT1A receptors; 5-HT release; AMPA/KA receptors; dorsal raphe nucleus; GABA receptors; NMDA receptors; medial prefrontal cortex
Copyright © 2001 Society for Neuroscience 0270-6474/01/21249917-13$05.00/0
This article has been cited by other articles:
E. Audero, E. Coppi, B. Mlinar, T. Rossetti, A. Caprioli, M. A. Banchaabouchi, R. Corradetti, and C. Gross
Sporadic Autonomic Dysregulation and Death Associated with Excessive Serotonin Autoinhibition
Science, July 4, 2008; 321(5885): 130 - 133.
[Abstract] [Full Text] [PDF]
J. H. G. Williams, D. I. Perrett, G. D. Waiter, and S. Pechey
Differential effects of tryptophan depletion on emotion processing according to face direction
Soc Cogn Affect Neurosci, December 1, 2007; 2(4): 264 - 273.
[Abstract] [Full Text] [PDF]
B. P. Guiard, J.-P. Guilloux, C. Reperant, S. P. Hunt, M. Toth, and A. M. Gardier
Substance P Neurokinin 1 Receptor Activation within the Dorsal Raphe Nucleus Controls Serotonin Release in the Mouse Frontal Cortex
Mol. Pharmacol., December 1, 2007; 72(6): 1411 - 1418.
[Abstract] [Full Text] [PDF]
P. Weikop, J. Kehr, and J. Scheel-Kruger
Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors
J Psychopharmacol, November 1, 2007; 21(8): 795 - 804.
[Abstract] [PDF]
J. E. Bermack and G. Debonnel
Effects of OPC-14523, a combined sigma and 5-HT1a ligand, on pre- and post-synaptic 5-HT1a receptors
J Psychopharmacol, January 1, 2007; 21(1): 85 - 92.
[Abstract] [PDF]
C. P. J. de Kock, L. N. Cornelisse, N. Burnashev, J. C. Lodder, A. J. Timmerman, J. J. Couey, H. D. Mansvelder, and A. B. Brussaard
NMDA receptors trigger neurosecretion of 5-HT within dorsal raphe nucleus of the rat in the absence of action potential firing
J. Physiol., December 15, 2006; 577(3): 891 - 905.
[Abstract] [Full Text] [PDF]
K Weissenborn, J C Ennen, M Bokemeyer, B Ahl, U Wurster, H Tillmann, C Trebst, H Hecker, and G Berding
Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment
Gut, November 1, 2006; 55(11): 1624 - 1630.
[Abstract] [Full Text] [PDF]
L. Diaz-Mataix, M. C. Scorza, A. Bortolozzi, M. Toth, P. Celada, and F. Artigas
Involvement of 5-HT1A Receptors in Prefrontal Cortex in the Modulation of Dopaminergic Activity: Role in Atypical Antipsychotic Action
J. Neurosci., November 23, 2005; 25(47): 10831 - 10843.
[Abstract] [Full Text] [PDF]
M.-B. Assie, V. Ravailhe, V. Faucillon, and A. Newman-Tancredi
Contrasting Contribution of 5-Hydroxytryptamine 1A Receptor Activation to Neurochemical Profile of Novel Antipsychotics: Frontocortical Dopamine and Hippocampal Serotonin Release in Rat Brain
J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 265 - 272.
[Abstract] [Full Text] [PDF]
M. R. Turner, E. A. Rabiner, A. Hammers, A. Al-Chalabi, P. M. Grasby, C. E. Shaw, D. J. Brooks, and P. N. Leigh
[11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS
Brain, April 1, 2005; 128(4): 896 - 905.
[Abstract] [Full Text] [PDF]
M. V. Puig, F. Artigas, and P. Celada
Modulation of the Activity of Pyramidal Neurons in Rat Prefrontal Cortex by Raphe Stimulation In Vivo: Involvement of Serotonin and GABA
Cereb Cortex, January 1, 2005; 15(1): 1 - 14.
[Abstract] [Full Text] [PDF]
P. R. Albert and S. Lemonde
5-HT1A Receptors, Gene Repression, and Depression: Guilt by Association
Neuroscientist, December 1, 2004; 10(6): 575 - 593.
[Abstract] [PDF]
M. V. Puig, N. Santana, P. Celada, G. Mengod, and F. Artigas
In Vivo Excitation of GABA Interneurons in the Medial Prefrontal Cortex through 5-HT3 Receptors
Cereb Cortex, December 1, 2004; 14(12): 1365 - 1375.
[Abstract] [Full Text] [PDF]
N. Santana, A. Bortolozzi, J. Serrats, G. Mengod, and F. Artigas
Expression of Serotonin1A and Serotonin2A Receptors in Pyramidal and GABAergic Neurons of the Rat Prefrontal Cortex
Cereb Cortex, October 1, 2004; 14(10): 1100 - 1109.
[Abstract] [Full Text] [PDF]
J. E. Bermack, N. Haddjeri, and G. Debonnel
Effects of the Potential Antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone Monomethanesulfonate] a Combined {sigma} and 5-HT1A Ligand: Modulation of Neuronal Activity in the Dorsal Raphe Nucleus
J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 578 - 583.
[Abstract] [Full Text] [PDF]
M. Amargos-Bosch, A. Bortolozzi, M. V. Puig, J. Serrats, A. Adell, P. Celada, M. Toth, G. Mengod, and F. Artigas
Co-expression and In Vivo Interaction of Serotonin1A and Serotonin2A Receptors in Pyramidal Neurons of Prefrontal Cortex
Cereb Cortex, March 1, 2004; 14(3): 281 - 299.
[Abstract] [Full Text] [PDF]
X.-M. Ou, S. Lemonde, H. Jafar-Nejad, C. D. Bown, A. Goto, A. Rogaeva, and P. R. Albert
Freud-1: A Neuronal Calcium-Regulated Repressor of the 5-HT1A Receptor Gene
J. Neurosci., August 13, 2003; 23(19): 7415 - 7425.
[Abstract] [Full Text] [PDF]
M. V. Puig, P. Celada, L. Diaz-Mataix, and F. Artigas
In Vivo Modulation of the Activity of Pyramidal Neurons in the Rat Medial Prefrontal Cortex by 5-HT2A Receptors: Relationship to Thalamocortical Afferents
Cereb Cortex, August 1, 2003; 13(8): 870 - 882.
[Abstract] [Full Text] [PDF]
R. Martin-Ruiz, M. V. Puig, P. Celada, D. A. Shapiro, B. L. Roth, G. Mengod, and F. Artigas
Control of Serotonergic Function in Medial Prefrontal Cortex by Serotonin-2A Receptors through a Glutamate-Dependent Mechanism
J. Neurosci., December 15, 2001; 21(24): 9856 - 9866.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|